Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer

Cancer Research

Volumn 58, Issue 2, 1998, Pages 342-347

  Ropponen, Kirsi ^a   Tammi, Markku ^a   Parkkinen, Jyrki ^a,b   Eskelinen, Matti ^b   Tammi, Raija ^a   Lipponen, Pertti ^a   Ågren, Ulla ^a   Alhava, Esko ^b   Kosma, Veli Matti ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PROTEOGLYCAN;

ADULT; AGED; ARTICLE; CANCER INVASION; COLON CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; SCORING SYSTEM; SURVIVAL RATE; WOUND HEALING;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0031973883     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Laurent, T. C., and Fraser, J. R. E. The properties and turnover of hyaluronan. In: D. Evered and J. Whelan (eds.), Functions of Proteoglycans. Ciba Foundation Symposium 124, pp. 9-29. New York: Wiley Chichester, 1986.
2. Ripellino, J. A., Klinger, M. M., Margolis, R. U., and Margolis, R. K. The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. J. Histochem. Cytochem., 33: 1060-1066, 1985.
3. Tammi, R., Rönkkö, S., Ågren, U., and Tammi, M. Distribution of hyaluronan in bull reproductive organs. J. Histochem. Cytochem., 42: 1479-1486, 1994.
4. Toole, B. P. Glycosaminoglycans in morphogenesis. In: E. D. Hay (ed.), Cell Biology of Extracellular Matrix, pp. 259-294. New York: Plenum Publishing Corp., 1981.
5. Knudson, W. Tumor-associated hyaluronan. Am. J. Pathol., 6: 1721-1726, 1996.
6. Arai, H., Kang, K-Y., Sato, H., Satoh, K., Nagai, H., Motomiya M., and Konno, K. Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am. Rev. Resp. Dis., 120: 529-532, 1979.
7. Hopwood, J., and Dorfman, A. Glycosaminoclycan synthesis by Wilms' tumor. Pediatr. Res., 12: 52-56, 1978.
8. Auvinen, P. K., Parkkinen, J. J., Ågren, U. M., Johansson, R. T., Tammi, R. H., Eskelinen, M. J., and Kosma, V-M. Expression of hyaluronan in benign and malignant breast lesions. Int. J. Cancer (Pred. Oncol.). 74: 477-481, 1997.
9. Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Höök, M., Moore, D., Cripps, V., Austen, L., Nance, D. M., and Turley, E. A. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell. Biol., 117: 1343-1350, 1992.
10. Knudson, W., Biswas, C., Li, X-Q., Nemec, R. E., and O'Toole, B. P. The role and regulation of tumor-associated hyaluronan. In: J. Whelan (ed.), The Biology of Hyaluronan, Ciba Foundation Symposium 143, pp. 150-169. New York: Wiley Chichester, 1989.
11. Yang, B., Zahang, L., and Turley, E. A. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J. Biol. Chem., 268: 8617-8623, 1993.
12. Peach, R. J., Hollenbaugh, D., Stamenkovic, I., and Aruffo, A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell. Biol., 22: 257-264, 1993.
13. Tanabe, K. K., Ellis, L. M., and Saya, H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341: 725-726, 1993.
14. Mulder, J. W. R., Kruyt, P. M., Sewnath, M., Oosting, J., Seldenrijk, C. A., Weidema, W. F., Offerhaus, G. J., and Pals, S. T. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344: 1470-1472, 1994.
15. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics 1994. CA Cancer J. Clin., 44: 7-26, 1994.
16. UICC. In: P. Hermanek and L. H. Sobin (eds.), TNM classification of malignant tumours, Ed. 4, pp. 52-55. Springer: Berlin, 1992.
17. Turnbull, R. B., Kyle, K., Watson, F. B., and Spratt, J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann. Surg., 166: 400-427, 1967.
18. Wang, C., Tammi, M., and Tammi, R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry, 98: 105-112, 1992.
19. Tammi, R., Ripellino, J. A., Margolis, R. U., Maibach, H. I., and Tammi, M. Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J. Invest. Dermatol., 92: 326-332, 1989.
20. Ropponen, K. M., Eskelinen, M. J., Lipponen, P. K., Alhava, E., and Kosma, V-M. Prognostic value of tumour infiltrating lymphocytes (TILs) in colorectal cancer. J. Pathol., 182: 318-324, 1997.
21. Mantel, N., and Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 22: 719-748, 1959.
22. Cox, D. R. Regression models and life tables with discussion. J. Roy. Stat. Soc. B, 34: 187-92, 1972.
23. Santra, M., Skorski, T., Calabretta, B., Lattime, E. C., and Iozzo, R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. USA, 92: 7016-7020, 1995.
24. Agrez, M. V., and Bates, R. C. Colorectal cancer and the integrin family of cell adhesion receptors: current status and future directions. Eur. J. Cancer, 30A: 2166-2170, 1994.
25. DeClerck, Y., and Laug, W. E. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Enzymes Proteins, 49: 72-84, 1996.
26. Crawford, H. C., and Matrician, L. M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis, 14: 234-245, 1994-5.
27. Wang, C., Tammi, M., Guo Hongtao, and Tammi, R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am. J. Pathol., 6: 1861-1869, 1996.
28. Turley, E. A., Austen, L., Moore, D., and Hoare, K. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only Rhamm is essential for hyaluronan-promoted locomotion. Exp. Cell Res., 207: 277-282, 1993.
29. Heider, K-H., Hofmann, M., Hors, E., Berg, F., Ponta, H., Herrlich, P., and Pals, S. A human homologue of rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120: 227-233, 1993.
30. Culty, M., Nguyen, H., and Underhill, C. The HA receptor (CD44) participates in the uptake and degradation of HA. J. Cell Biol., 116: 1055-1062, 1992.
31. Hua, Q., Knudson, C., and Knudson, W. Internalization of hyaluronan by chondrocytes occurs via receptor mediated endocytosis. J. Cell Sci., 106: 365-375, 1993.
32. Culty, M., Shizari, M., Thompson, E. W., and Underhill, C. B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J. Cell. Physiol., 160: 275-286, 1994.
33. Prehm, P. Hyaluronate is synthesized at plasma membranes. Biochem. J., 220: 597-600, 1984.
34. Weigel, P. H., Hascall, V. C., and Tammi, M. Hyaluronan synthases. J. Biol. Chem., 22: 13997-14000, 1997.
35. Knudson, W., Biswas, C., and Toole, B. P. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc. Natl. Acad. Sci. USA, 81: 6767-8771, 1984.
36. Rooney, P., Kumar, S., Ponting, J., and Wang, M. The role of hyaluronan in tumour neovascularization. Int. J. Cancer, 60: 632-636, 1995.
37. Liu, D., Pearlman, E., Diaconu, E., Guo, K., Mori, H., Haqqi, T., Markowitz, S., Willson, J., and Sy, M. S. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA, 93: 7832-7837, 1996.
38. Lokeshwar, V., Lokeshwar, B., Pham, H., and Block, N. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res., 56: 656-657, 1996.
39. McBride, W. H., and Bard, J. B. Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J. Exp. Med., 149: 507-515, 1979.
40. Höbarth, K., Maier, U., and Marberger, M. Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase. Eur. Urol., 21: 206-210, 1992.
41. Beckenlehner, K., Bannke, S., Spruss, T., Bernhardt, G., Schonenberg, H., and Schiess, W. Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo. J. Cancer Res. Clin. Oncol., 118: 591-596, 1992.
42. Kohno, N., Ohnuma, T., and Truog, P. Effects of hyaluronidase on doxorabicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality. J. Cancer Res. Clin. Oncol., 120: 293-297, 1994.
43. Zhang, L., Underhill, C. B., and Chen, L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55: 428-433, 1995.
44. Weigel, P. H., Frost, S. J., Leboeuf, R. D., and McGary, C. T. The specific interaction between fibrin(ogen) and hyaluronan: possible consequences in haemostasis, inflammation and wound healing. In: D. Evered and J. Whelan (eds.), The Biology of Hyaluronan, Ciba Foundation Symposium 143, pp. 248-264. New York: Wiley Chichester, 1989.
45. Sleeman, J., Arming, S., Moll, J., Hekele, A., Rudy, W., Sherman, L., Kreil, G., Ponta, H., and Herrlich, P. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res., 56: 3134-3141, 1996.
46. Jaworski, D., Kelly, G., Piepmeier, J., and Hockfield, S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res., 56: 2293-2298, 1996.
47. Hall, C., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., Greenberg, A., and Turley, E. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell, 82: 19-28, 1995.
48. Shirasawa, S., Furuse, M., Yokoyama, N., and Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (Washington DC), 260: 85-88, 1993.